Top compounds associated with response to ATL2


Feature Type Standardized
Nominal ANOVA
mRNA AT7867 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA lapatinib GDSC1000 pan-cancer AAC 0.043 0.4
mRNA SZ4TA2 CTRPv2 pan-cancer AAC -0.049 0.4
mRNA IOX2 GDSC1000 pan-cancer AAC -0.031 0.4
mRNA CIL70 CTRPv2 pan-cancer AAC 0.042 0.4
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.031 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA SN-38 GDSC1000 pan-cancer AAC 0.03 0.4
Download CSV